Peter Ruus
Impact in
- Biochemistry top 1%
- Biochemical Acid Research Studies
- Antioxidant Activity and Oxidative Stress
-
- Diabetes Treatment and Management
- Natural Antidiabetic Agents Studies
Papers in
-
- Biochemical Acid Research Studies 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Jens Teichert (2 shared papers)Rainer Preiß (2 shared papers)Christoph Kapitza (1 shared paper)Franck Poitiers (1 shared paper)Agnès Hincelin-Méry (1 shared paper)Thomas M. Forst (1 shared paper)Hans Veit Coester (1 shared paper)Elke Maerker (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Free Radical Biology and Medicine (1 paper)mAbs (1 paper)
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Peter Ruus
13 papers receiving 873 citations
Peers
Comparison fields: 5 of 79
- Biochemistry 255
- Endocrinology, Diabetes and Metabolism 330
- Biochemistry 45
- Pharmacology 57
- Gastroenterology 29
Countries citing papers authored by Peter Ruus
This map shows the geographic impact of Peter Ruus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruus more than expected).
Fields of papers citing papers by Peter Ruus
This network shows the impact of papers produced by Peter Ruus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruus. The network helps show where Peter Ruus may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ruus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 234 | |
| 2 | 2013 | 170 | |
| 3 | 2013 | 131 | |
| 4 | 2003 | 128 | |
| 5 | 1996 | 102 | |
| 6 | 1999 | 70 | |
| 7 | 2005 | 54 | |
| 8 | 2003 | 44 | |
| 9 | 1994 | 18 | |
| 10 | 1998 | 18 | |
| 11 | 2019 | 8 | |
| 12 | Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate. | 1998 | 3 |
| 13 | Absolute bioavailability of flupirtine capsules drops and suppositories in man | 1995 | 1 |
About Peter Ruus
Peter Ruus is a scholar working on Biochemistry, Pharmacology, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Gastroenterology, having authored 13 papers that have together received 981 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Biochemical Acid Research Studies (4 papers), Diabetes Treatment and Management (2 papers), Pharmaceutical studies and practices (2 papers), Epilepsy research and treatment (1 paper), Drug Solubulity and Delivery Systems (1 paper), Blood Pressure and Hypertension Studies (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Biochemistry (255 citations), Endocrinology, Diabetes and Metabolism (330 citations), Biochemistry (45 citations), Pharmacology (57 citations) and Gastroenterology (29 citations). Peter Ruus has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Jens Teichert, Rainer Preiß, Christoph Kapitza, Franck Poitiers, Agnès Hincelin-Méry, Thomas M. Forst, Hans Veit Coester, Elke Maerker, Hans Tritschler and Augustin Hj. Their work appears in journals such as The Journal of Clinical Pharmacology, European Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics, Free Radical Biology and Medicine and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.